Levi & Korsinsky Urges V.F. Corporation (VFC) Shareholders to Act Before Lead Plaintiff Deadline November 12, 2025

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173775&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Securities Lawsuit Alert: Cytokinetics, Incorporated (CYTK) – Contact Levi & Korsinsky Before November 17, 2025

NEW YORK, NY / ACCESS Newswire / October 24, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=173774&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Neinor Homes completes EUR140mn ABB, eyeing further growth opportunities in a buoyant Spanish Residential market

(Madrid:HOME), MADRID, 24th of October of 2025 – Neinor successfully raised EUR140mn through an accelerated bookbuild offering (ABB) through the issuance of 8,900,190 new shares at EUR15.73/sh Orion, Neinor's largest shareholder, subscribed EUR100mn, reinforcing its long-term commitment to the company and confidence on its equity efficient growth strategy An additional EUR40mn was subscribed by existing

Neinor Homes completes EUR140mn ABB, eyeing further growth opportunities in a buoyant Spanish Residential market

Neinor Homes completes EUR140mn ABB, eyeing further growth opportunities in a buoyant Spanish Residential market GlobeNewswire October 24, 2025 MADRID, 24th of October of 2025 – Neinor successfully raised EUR140mn through an accelerated bookbuild offering (ABB) through the issuance of 8,900,190 new shares at EUR15.73/sh Orion, Neinor's largest shareholder, subscribed EUR100mn, reinforcing its long-term commitment

Calumet, Inc. to Release Third Quarter 2025 Earnings on November 7, 2025

Calumet, Inc. (NASDAQ: CLMT) (the “Company,” “Calumet,” “we,” “our” or “us”), announced today that it plans to report results for the Third Quarter 2025 onNovember 7, 2025. A conference call to discuss the financial and operational results is scheduled forNovember 7th at9:00 AM ET. Investors, analysts and members of the media interested in listening to

Hong Kong Stock Exchange Gains Traction Amid Global Headwinds, Says Brightyear Consultants

Hong Kong Stock Exchange Gains Traction Amid Global Headwinds, Says Brightyear Consultants GlobeNewswire October 24, 2025 HONG KONG, Oct. 24, 2025 (GLOBE NEWSWIRE) — Brightyear Consultants has issued its latest market commentary on the Hong Kong Stock Exchange (HKEX), observing a clear uptrend supported by stabilizing valuations, strong corporate earnings, and increased cross-border capital flows.

Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN

GUIGANG, China, Oct. 24, 2025 (GLOBE NEWSWIRE) — Recently, at the platform of the 22nd China-ASEAN Expo, the Government of Gangnan District, Guigang City, Guangxi successfully signed a cooperation agreement with Shandong Jinyuan Wood Industry Co., Ltd. It is planned to construct a production line and supporting facilities with an annual output of 40 million

Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN

Gangnan District, Guigang City, Guangxi: Building a Wood-Based Smart Home Industry Cluster Facing ASEAN GlobeNewswire October 24, 2025 GUIGANG, China, Oct. 24, 2025 (GLOBE NEWSWIRE) — Recently, at the platform of the 22nd China-ASEAN Expo, the Government of Gangnan District, Guigang City, Guangxi successfully signed a cooperation agreement with Shandong Jinyuan Wood Industry Co., Ltd.

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

(NASDAQ:KURA), – Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program- SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced receipt of a $30 million milestone payment

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin

Kura Oncology Receives $30 Million Development Milestone Payment in Ziftomenib AML Program with Kyowa Kirin GlobeNewswire October 24, 2025 – Milestone triggered by dosing of first patient in frontline AML Phase 3 clinical program- SAN DIEGO, Oct. 24, 2025 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the

Scroll to Top